The anticancer effect of protein-extract from Bidens alba in human colorectal carcinoma SW480 cells via the reactive oxidative species- and glutathione depletion-dependent apoptosis

Food and Chemical Toxicology

Volumn 46, Issue 5, 2008, Pages 1535-1547

  Ong, Ping Lin ^a   Weng, Bor Chun ^a   Lu, Fung Jou ^b   Lin, Miao Ling ^c   Chang, Ting Ting ^d   Hung, Ray Ping ^e   Chen, Ching Hsein ^a  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e FOOYIN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bidens alba; Colorectal carcinoma; Glutathione depletion; Reactive oxidative species

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BIDENS ALBA EXTRACT; BUTYLOXYCARBONYLASPARTYL O METHYL ESTER FLUOROMETHYL KETONE; CASPASE INHIBITOR; CYTOCHROME C; GLUTATHIONE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIDENS; BIDENS ALBA; CANCER CELL CULTURE; CELL STRUCTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; DNA DAMAGE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIDENS; CASPASES; CELL COUNT; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; CYTOCHROMES C; CYTOSOL; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; IN SITU NICK-END LABELING; INDICATORS AND REAGENTS; MITOCHONDRIA; PLANT EXTRACTS; PLANT PROTEINS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; THIAZOLES;

BIDENS ALBA;

EID: 40849113023     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.12.015     Document Type: Article

References (33)

1. Biroccio A., Benassi B., Fiorentino F., and Zupi G. Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents. Neoplasia 6 (2004) 195-206
2. Chen G.G., Liang N.C., Lee J.F., Chan U.P., Wang S.H., Leung B.C., and Leung K.L. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 9 (2004) 619-627
3. Chen C.Y., Liu T.Z., Liu Y.W., Tseng W.C., Liu R.H., Lu F.J., Lin Y.S., Kuo S.H., and Chen C.H. 6-shogaol (alkanone from ginger) induces apoptotic cell death of human hepatoma p53 mutant Mahlavu subline via an oxidative stress-mediated caspase-dependent mechanism. J. Agric. Food Chem. 55 (2007) 948-954
4. Chi L., Ke Y., Luo C., Gozal D., and Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144 (2007) 991-1003
5. Cunningham D., Humblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., Bets D., Mueser M., Harstrick A., and Verslype C. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 351 (2004) 337-345
6. De Mejia E.G., and Prisecaru V.I. Lectins as bioactive plant proteins: a potential in cancer treatment. Crit. Rev. Food Sci. Nutr. 45 (2005) 425-445
7. Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., Jandik P., Iveson T., Carmichael J., and Alakl M. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
8. Gali-Muhtasib H., Diab-Assaf M., Boltze C., Al-Hmaira J., Hartig R., Roessner A., and Schneider-Stock R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int. J. Oncol. 25 (2004) 857-866
9. Ghribi O., Herman M.M., Spaulding N.K., and Savory J. Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J. Neurochem. 82 (2002) 137-145
10. Giacchetti S., Perpoint B., Zidani R., Le Bail N., Faggiuolo R., Focan C., Chollet P., Llory J.F., Letourneau Y., and Coudert B. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J. Clin. Oncol. 18 (2000) 136-147
11. Han J., Goldstein L.A., Gastman B.R., and Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J. Biol. Chem. 281 (2006) 10153-10163
12. Higuchi Y. Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J. Cell. Mol. Med. 8 (2004) 455-464
13. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., and Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350 (2004) 2335-2342
14. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 57 (2007) 43-66
15. Jing Y., Yang J., Wang Y., Li H., Chen Y., Hu Q., Shi G., Tang X., and Yi J. Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappa B are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radic. Biol. Med. 40 (2006) 2183-2197
16. Kim Y.J., Kang S.A., Hong M.S., Park H.J., Kim M.J., Park H.J., and Kim H.K. Coptidis rhizoma induces apoptosis in human colorectal cancer cells SNU-C4. Am. J. Chin. Med. 32 (2004) 873-882
17. Lans C.A. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J. Ethnobiol. Ethnomed. 2 (2006) 45
18. Lans C. Comparison of plants used for skin and stomach problems in Trinidad and Tobago with Asian ethnomedicine. J. Ethnobiol. Ethnomed. 3 (2007) 3
19. Laube G.F., Shah V., Stewart V.C., Hargreaves I.P., Haq M.R., Heales S.J., and van't Hoff W.G. Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells. Pediatr. Nephrol. 21 (2006) 503-509
20. Levedeva I.V., Washington I., Sarkar D., Clark J.A., Fine R.L., Dent P., Curiel D.T., Turro N.J., and Fisher P.B. Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Proc. Natl. Acad. Sci. USA 104 (2007) 3484-3489
21. Lu G., Ren S., Korge P., Choi J., Dong Y., Weiss J., Koehler C., Chen J.N., and Wang Y. A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes Dev. 21 (2007) 784-796
22. Lucke J.F. Student's t test and the Glasgow Coma Scale. Ann. Emerg. Med. 28 (1996) 408-413
23. Mitchell C., Park M.A., Zhang G., Han S.I., Harada H., Franklin R.A., Yacoub A., Li P.L., Hylemon P.B., Grant S., and Dent P. 17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines. Mol. Cancer Ther. 6 (2007) 618-632
24. Neuzil J., Wang X.F., Dong L.F., Low P., and Ralph S.J. Molecular mechanism of'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 580 (2006) 5125-5129
25. Olsnes S. The history of ricin, abrin and related toxins. Toxicon 44 (2004) 361-370
26. Pook S.H., Toh C.K., and Mahendran R. Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity. Cancer Lett. 238 (2006) 146-152
27. Pryme I.F., Bardocz S., Pusztai A., and Ewen S.W. Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins. Histol. Histopathol. 21 (2006) 285-299
28. Ramos A.M., Fernandez C., Amran D., Esteban D., de Blas E., Palacios M.A., and Aller P. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. J. Cell. Physiol. 209 (2006) 1006-1015
29. Sung J.J., Lau J.Y., Goh K.L., and Leung W.K. Asia Pacific working group on colorectal cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 6 (2005) 871-876
30. Voss C., Eyol E., Frank M., von der Lieth C.W., and Berger M.R. Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J. 20 (2006) 1194-1196
31. Voss C., Eyol E., and Berger M.R. Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. Toxicol. Appl. Pharmacol. 211 (2006) 177-187
32. Xie J.T., Wang C.Z., Wicks S., Yin J.J., Kong J., Li J., Li Y.C., and Yuan C.S. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp. Oncol. 28 (2006) 25-29
33. Zarovni N., Vago R., Solda T., Monaco L., and Fabbrini M.S. Saporin as a novel suicide gene in anticancer gene therapy. Cancer Gene Ther. 14 (2007) 165-173